Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial.

Add item related to this paper

  • MiniManuscript ID
    1789
  • Pubmed ID
    16433711